RPG Life Sciences notifies shareholders via email about updated dividend taxation provisions for FY 2024–25. Read the official company update here.
RPG Life Sciences Ltd Updates Shareholders on Dividend Taxation Provisions
Mumbai, India – June 5, 2025 – In a recent corporate update, RPG Life Sciences Ltd (BSE: 532983) has formally communicated to its shareholders regarding the latest provisions related to dividend taxation.
The message, which has been emailed, seeks to guide and inform the investors regarding relevant tax regulations and procedures for the next financial year 2024–25.
The company, a well-established player in the pharmaceutical sector, issued this update as part of its ongoing commitment to corporate transparency and compliance with shareholder communication norms under the Companies Act and SEBI’s Listing Obligations and Disclosure Requirements (LODR).
Purpose of the Email Communication
The mail is specifically relating to the tax structure levied on dividends announced by the company. According to the Indian Income Tax Act, 1961, dividends received by companies are taxable in shareholders’ hands. RPG Life Sciences has reminded shareholders to get appropriate documentation and declaration for availing lower withholding tax rates, if covered by Double Taxation Avoidance Agreements (DTAA).
This is very important before any announcement of a final or interim dividend for the financial year. The company urges shareholders, particularly non-resident investors, to present valid documents like PAN, Form 10F, TRC (Tax Residency Certificate), and declaration forms in a timely manner to prevent extra tax deduction at source.
Regulatory Context
Since the abolishment of the Dividend Distribution Tax (DDT) regime in FY 2020–21, dividends are now taxed in the hands of recipients.This implies that persons and institutions that receive dividends are liable to income tax rates that apply, and the companies have to withhold tax.
According to the terms of Section 194 of the Income Tax Act, resident shareholders are taxed under TDS at 10%, while non-resident shareholders can be taxed at a higher rate unless DTAA relief is availed.
RPG Life Sciences’ notice echoes the firm’s duty to deduct tax at the highest rate if shareholders fail to provide the necessary information in the specified time.
What Shareholders Should Do
More Read
The company urges all shareholders to act promptly and submit the required documents through the company’s designated registrar or investor services portal. This includes:
- Valid PAN (Permanent Account Number)
- Self-attested Form 15G/15H, if applicable
- Tax Residency Certificate (TRC) for non-residents
- Form 10F for DTAA benefits
- Any other declaration form required for lower or nil deduction
The communication also contains step-by-step guidance and links to the submission portals to ensure ease of compliance.
About RPG Life Sciences Ltd
RPG Life Sciences is a prime Mumbai-based pharmaceutical company and part of the RPG Enterprises group. RPG Life Sciences produces and sells bulk drugs and formulations in domestic as well as overseas markets. It supplies products with a major focus on R&D and compliance with regulations in overseas markets.
With this shareholder-oriented approach, RPG Life Sciences is able to maintain its record of sound governance, fiscal prudence, and lawfulness.
More Information
For full details, shareholders can access the official communication and relevant forms via the BSE announcement page.
